IngentaConnect Search Results

Levofloxacin: A Review of its Use as a High-Dose, Short-Course Treatment for Bacterial Infection

Authors: Anderson, Vanessa R.; Perry, Caroline M.

Source: Drugs, Volume 68, Number 4, 2008 , pp. 535-565(31)

A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis

Authors: Klausner, Howard A.; Brown, Patricia; Peterson, Janet; Kaul, Simrati; Khashab, Mohammed; Fisher, Alan C.; Kahn, James B.

Source: Current Medical Research and Opinion, Volume 23, Number 11, November 2007 , pp. 2637-2645(9)

Publisher: Informa Healthcare

Syntheses and crystal structures of two samarium(III) complexes with bio-relevant ligands

Authors: Chen, Zhen-Feng; Yu, Liang-Cai; Zhang, Ming; Yuan, Tao; Liang, Hong; Fun, Hoong-Kun; Zhang, Yong

Source: Journal of Coordination Chemistry, Volume 60, Number 2, 2007 , pp. 219-228(10)

Publisher: Taylor and Francis Ltd

Levofloxacin for the treatment of community-acquired pneumonia

Authors: Lynch III, Joseph P; File Jr, Thomas M; Zhanel, George G

Source: Expert Review of Anti-Infective Therapy, Volume 4, Number 5, October 2006 , pp. 725-742(18)

Publisher: Expert Reviews

Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience

Authors: Tennenberg, Alan M.; Davis, Neelam B.; Wu, Shu-Chen; Kahn, James

Source: Current Medical Research and Opinion, Volume 22, Number 5, May 2006 , pp. 843-850(8)

Publisher: Informa Healthcare

Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study

Authors: Schrijvers D.; Van Herpen C.; Kerger J.; Joosens E.; Van Laer C.; Awada A.; Van den Weyngaert D.; Nguyen H.; Le Bouder C.; Castelijns J.A.; Kaanders J.; De Mulder P.; Vermorken J.B.

Source: Annals of Oncology, Volume 15, Number 4, April 2004 , pp. 638-645(8)

Publisher: Oxford University Press

Comparative antimicrobial activity of levofloxacin and ciprofloxacin against Streptococcus pneumoniae

Author: Mark W. Garrison

Source: Journal of Antimicrobial Chemotherapy, Volume 52, Number 3, September 2003 , pp. 503-506(4)

Publisher: Oxford University Press

Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: A multicenter, prospective, randomized, open-label study

Authors: West M.; Boulanger B.R.; Fogarty C.; Tennenberg A.; Wiesinger B.; Oross M.; Wu S.-C.; Fowler C.; Morgan N.; Kahn J.B.

Source: Clinical Therapeutics, Volume 25, Number 2, February 2003 , pp. 485-506(22)

Publisher: Elsevier

Pharmacodynamics of 750 mg and 500 mg doses of levofloxacin against ciprofloxacin-resistant strains of Streptococcus pneumoniae

Author: Lister P.D.

Source: Diagnostic Microbiology and Infectious Disease, Volume 44, Number 1, September 2002 , pp. 43-49(7)

Publisher: Elsevier

Successful treatment of orthodontic-associated traumatic endophthalmitis

Authors: Wirostko W.J.; Kivlin J.D.

Source: American Journal of Ophthalmology, Volume 134, Number 3, September 2002 , pp. 449-450(2)

Publisher: Elsevier

Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study

Authors: Tjan-Heijnen V.C.G.; Postmus P.E.; Ardizzoni A.; Manegold C.; Burghouts J.; van Meerbeeck J.; Gans S.; Mollers M.; Buchholz E.; Biesma B.; Legrand C.; Debruyne C.; Giaccone G.

Source: Annals of Oncology, Volume 12, Number 10, October 2001 , pp. 1359-1368(10)

Publisher: Springer

Which fluoroquinolones are suitable for the treatment of urinary tract infections?

Author: Naber K.G.

Source: International Journal of Antimicrobial Agents, Volume 17, Number 4, April 2001 , pp. 331-341(11)

Publisher: Elsevier

Intravenous and oral mono- or combination-therapy in the treatment of severe infections: ciprofloxacin versus standard antibiotic therapy

Authors: Krumpe, Peter E.; Cohn, Stephen; Garreltes, James; Ramirez, Julio; Coulter, Holly; Haverstock, Daniel; Echols, Roger; Ciprofloxacin Study Group,

Source: Journal of Antimicrobial Chemotherapy, Volume 43, Supplement 1, March 1999 , pp. 117-128(12)

Publisher: Oxford University Press

Sparfloxacin Versus Ciprofloxacin for the Treatment of Community-Acquired, Complicated Skin and Skin-Structure Infections

Authors: Lipsky B.A.; Miller B.; Schwartz R.; Henry D.C.; Nolan T.; McCabe A.; Magner D.J.; Talbot G.H.

Source: Clinical Therapeutics, Volume 21, Number 4, April 1999 , pp. 675-690(16)

Publisher: Elsevier

Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci

Authors: Entenza, José M.; Caldelari, Isabelle; Glauser, Michel P.

Source: Journal of Antimicrobial Chemotherapy, Volume 44, Number 6, December 1999 , pp. 775-786(12)

Publisher: Oxford University Press

Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae

Authors: Lister, PD; Sanders, CC

Source: Journal of Antimicrobial Chemotherapy, Volume 43, Number 1, January 1999 , pp. 79-86(8)

Publisher: Oxford University Press

Efficacy and tolerability of twice-daily ciprofloxacin 750 mg in the treatment of patients with acute exacerbations of chronic bronchitis and pneumonia

Authors: Pryka R.; Kowalsky S.; Haverstock D.

Source: Clinical Therapeutics, Volume 20, Number 1, January 1998 , pp. 141-155(15)

Publisher: Elsevier

Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg BID versus clarithromycin 500 mg BID

Authors: Anzueto A.; Niederman M.S.; Tillotson G.S.; Bronchitis Study Group

Source: Clinical Therapeutics, Volume 20, Number 5, September 1998/October 1998 , pp. 885-900(16)

Publisher: Elsevier

Efficacy of ciprofloxacin and clarithromycin in acute bacterial exacerbations of complicated chronic bronchitis: interim analysis

Authors: Anzueto A.; Niederman M.S.; Haverstock D.C.; Tillotson G.S.; Bronchitis Study Group

Source: Clinical Therapeutics, Volume 19, Number 5, September 1997 , pp. 989-1001(13)

Publisher: Elsevier

Lack of gender effect on ciprofloxacin pharmacokinetics in humans

Authors: GALLICANO, KEITH; SAHAI, JAN

Source: British Journal of Clinical Pharmacology, Volume 42, Number 5, November 1996 , pp. 632-634(3)

Publisher: Blackwell Publishing